Insider Stock Trading History of Bryson Vaughn D


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Bryson Vaughn D since year 2005. The trader's CIK number is 1189539. At the time of this reporting, Bryson Vaughn D is the Director of Atherogenics Inc . (stock ticker symbol AGIX). See this page for all insider trading activities at Atherogenics Inc .

Note that in the past BRYSON VAUGHN D also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Bryson Vaughn D since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2008-01-22 AGIX Atherogenics Inc Sale 3,386 .39 1,320
2008-02-08 AGIX Atherogenics Inc Buy 50,000 .64 32,000
2007-12-27 AGIX Atherogenics Inc Sale 48,732 .40 19,492
2007-12-28 AGIX Atherogenics Inc Sale 24,733 .38 9,448
2007-12-26 AGIX Atherogenics Inc Sale 2,440 .40 976
2007-12-20 AGIX Atherogenics Inc Sale 7,657 .43 3,292
2007-08-29 AGIX Atherogenics Inc Sale 55,518 2.15 119,363
2006-06-29 AGIX Atherogenics Inc Buy 22,868 12.97 296,643
2006-06-30 AGIX Atherogenics Inc Buy 17,132 13.06 223,778
2006-05-30 AGIX Atherogenics Inc Buy 20,000 13.87 277,460
2005-05-06 AMLN Amylin Pharmaceuticals Inc Buy 20,000 16.72 334,300
2005-03-31 ICOS Icos Corp / De Buy 5,000 22.54 112,705

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bryson Vaughn D (Director of Atherogenics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.